Vets hail vaccine authorisation
PHARMAQ has been granted a new marketing authorisation in the UK and Ireland for its multicomponent vaccine containing Moritella component.
The Alpha Ject micro 6 vaccine, a POM-V (prescription only medicine – veterinarian), is indicated for use in Atlantic salmon to reduce mortality caused by infections with Aeromonas salmonicida (furunculosis) Vibrio salmonicida (coldwater vibriosis), Listonella anguillarum serotype O1 and O2 (vibriosis), Moritella viscosa (winter sore) and IPNV (infectious pancreatic necrosis).
Up until now, veterinarians wishing to prescribe this vaccine for Scottish fish have had to do so with authorisation from the Veterinary Medicines Directorate through the issue of a Special Import Certificate.(SIC).With the removal of the SIC requirement, under which 50 million doses have hitherto been deployed in the UK alone, Pharmaq will be able to supply the local industry with the only Moritella component vaccine that enjoys a full MA in the UK and Ireland.
Alpha Ject micro 1PD, also a POM-V medicine, already enjoys a full MA in the UK and Ireland.This contains Salmon Pancreas Disease Virus (SPDV) for active immunisation of Atlantic salmon to reduce clinical signs (heart lesions and pancreas lesions), viraemia, viral shedding and mortality from infection with SPDV (pancreas disease).
It is documented for combined use with Alpha Ject micro 6, thus the two vaccines can provide a flexible solution for vaccination of salmon.